Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-kit positive acute myeloid leukemia. Results of an italian multicentric phase II study

Autor:	Piccaluga, Pp, Martinelli, G, Malagola, Michele, Rondoni, M, Arpinati, M, Tazzari, Pl, Amabile, M, Ottavini, E, Fanin, R, Cilloni, D, Saglio, G, Lauria, F, Visani, G, Russo, Domenico, Baccarani, M.
Jazyk:	angličtina
Rok vydání:	2007
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3662::ba81f7bac899c541a46ee37d85c8dcbc http://hdl.handle.net/11379/133518 Zobrazit plný text záznamu